Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/1995
10/18/1995EP0677061A1 Polypeptide and anti-hiv agent prepared therefrom
10/18/1995EP0677050A1 Novel pyridone carboxylic acid derivatives
10/18/1995EP0677039A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
10/18/1995EP0676966A1 Antibodies directed against binding-associated epitopes
10/18/1995EP0676958A1 Method for inhibiting intracellular viral replication
10/18/1995EP0676954A1 Human immunodeficiency virus decoy
10/18/1995EP0596935B1 Antiviral pharmaceutical compositions for vaginal administration
10/18/1995EP0576478B1 Herpes simplex vaccine comprising hsv glycoprotein gd and 3 deacylated monophosphoryl lipid a
10/18/1995EP0495116B1 Anti-human immunodeficiency virus agent
10/18/1995CN1110479A Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
10/18/1995CN1110477A Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1110280A Targeted forms of methyltrithio antitumor agents
10/18/1995CN1110150A Jiawei double coptis medicament and preparing method thereof
10/17/1995US5459255 For incorporation into oligonucleotides, cleaving RNA site specifically
10/17/1995US5459238 Stimulate cytototoxic T lymphocyte immunity by interacting with human leucocyte antigen; possible AIDS vaccine
10/17/1995US5459235 Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
10/17/1995US5459159 Anticarcinogenic/antitumor agents; allowing accumulation in abnormal cells, irradiation with light of specified wavelength
10/17/1995US5459141 Compounds 31668P and 31668U, a process for their production and their use
10/17/1995US5459127 Cationic lipids for intracellular delivery of biologically active molecules
10/17/1995US5459060 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
10/17/1995CA1337333C Legionellosis vaccines and methods for their production
10/17/1995CA1337331C Intranasal vaccination of horses with inactivated micro-organisms or antigenic material
10/17/1995CA1337330C Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
10/17/1995CA1337328C Odorless aromatic dialdehyde disinfecting and sterilizing composition
10/15/1995CA2163890A1 Dc-89 derivative
10/12/1995WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
10/12/1995WO1995027053A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY
10/12/1995WO1995027052A1 Human interleukin variants generated by alternative splicing
10/12/1995WO1995027046A2 Enzymatic antimicrobial compositions containing haloperoxidases
10/12/1995WO1995027044A1 ALPHAVIRUS cDNA VECTORS
10/12/1995WO1995027043A1 Antibacterial therapy with genotypically modified bacteriophage
10/12/1995WO1995026972A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
10/12/1995WO1995026962A1 Thiazolylpyrazolinones and their use for protecting technical materials
10/12/1995WO1995026960A1 Physiologically active substance ei-1507
10/12/1995WO1995026751A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR
10/12/1995WO1995026743A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995WO1995026718A1 Compositions and methods for delivery of genetic material
10/12/1995WO1995024923A3 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
10/12/1995CA2187200A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995CA2186962A1 Antibacterial therapy with genotypically modified bacteriophage
10/12/1995CA2186913A1 Compositions and methods for delivery of genetic material
10/12/1995CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity
10/12/1995CA2186854A1 Human interleukin variants generated by alternative splicing
10/12/1995CA2186635A1 .alpha.-1-antichymotrypsin analogues having chymase inhibiting activity
10/12/1995CA2186250A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
10/12/1995CA2184261A1 Alphavirus cdna vectors
10/12/1995CA2182966A1 Enzymatic antimicrobial compositions
10/11/1995EP0676467A2 European vaccine strains of the porcine reproductive respiratory syndrome virus (PRRSV)
10/11/1995EP0676409A1 Erythromycin derivatives, their process for preparation and their application as medicaments
10/11/1995EP0676198A1 Fungicidal compositions containing a combination of bifonazole and fluocinonide
10/11/1995EP0675961A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/11/1995EP0675957A1 Vaccines against varicella-zoster virus (vzv)
10/11/1995EP0675955A1 Molecular flashlight
10/11/1995EP0675904A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus
10/11/1995EP0675900A1 Antibiotics ge 37468 a, b and c
10/11/1995EP0675730A1 Therapeutic combination containing interferon
10/11/1995EP0675719A1 Novel combination of benzoquinazoline antifolates and protecting agents
10/11/1995EP0575425B1 USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES
10/11/1995CN1109908A Productive process and use of human anti-tumour alpha type interferon alpha 1/114 Ala, alpha 1/158 Val and mutant thereof
10/11/1995CN1109890A 9a-N-(N'-carbamoyl) and 9a-N-(N'-thiocaramoyl) derivatives of 9-deoxo-9a-aza-9a-homoerythromycin A
10/11/1995CN1109763A Vaccinal efficacy augmentor and efficacy-augmenting foods
10/11/1995CN1029971C Process for preparating antiviral tetrahydroimidazo (1,4) benzodiazepines
10/11/1995CN1029966C Crystalline beta-lactan hydrate
10/11/1995CN1029965C Process and intermediates for beta-lactams having aminothiazole (iminoxyacetic acid) acetic acid sidechains
10/10/1995US5457189 Antisense oligonucleotide inhibition of papillomavirus
10/10/1995US5457129 Inhibition of nitric oxide production by retinoic acid
10/10/1995US5457119 A89271 factors and processes for their production
10/10/1995US5457108 Viricides for treating retroviruses
10/10/1995US5457104 Quinolone- and naphthyridonecarboxylic acid derivatives
10/10/1995US5457096 Antibiotic
10/10/1995US5457091 N1-substituted 1H-1,2,3-triazolo[4,5,-D]pyrimidines, a process for their preparation and their use as antiviral agents
10/10/1995US5457090 A serine proteolytic enzyme inhibitor
10/10/1995US5457038 Natural killer stimulatory factor
10/10/1995US5456924 Method of treatment of HIV-seropositive individuals with dietary whey proteins
10/10/1995CA1337279C Intravaginal treatment of vaginal infections with buffered metronidazole compositions
10/10/1995CA1337267C Canine coronavirus vaccine
10/05/1995WO1995026361A1 Vpr AND Vpx PROTEINS OF HIV
10/05/1995WO1995026352A1 IMIDAZO[1,2-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026351A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026350A1 Imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one derivatives and pharmaceutical compositions containing same
10/05/1995WO1995026349A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026202A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
10/05/1995WO1995026197A1 Adhesion inhibiting composition
10/05/1995WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
10/05/1995WO1995026191A1 Injectable solutions of dirithromycin
10/05/1995WO1995026134A1 Composition for inactivating irritants in fluids
10/05/1995DE4411235A1 Thiazolylpyrazolinone Thiazolylpyrazolinone
10/05/1995DE4411025A1 New lipopeptide A1437 derivs. with modified acyl gp.
10/05/1995CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon
10/05/1995CA2186398A1 Vpr and vpx proteins of hiv
10/05/1995CA2186390A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
10/05/1995CA2186377A1 Adhesion inhibiting composition
10/04/1995EP0675199A2 A DNA which codes for the variable region of the anti-human influenza A type virus antibody recognizing the H,N, and H2N2 subtypes of haemagglutinin
10/04/1995EP0675122A2 Mono or bicyclic DNA gyrase inhibitors
10/04/1995EP0674905A2 Bacterin for the treatment of necrophorum diseases and a method for the production thereof
10/04/1995EP0674707A1 Compounds and methods for the treatment of leukemias
10/04/1995EP0674657A1 Gp41 mutants and their use as hiv therapeutics
10/04/1995EP0674646A1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
10/04/1995EP0674643A1 Coumarin derivatives as retroviral inhibitors